Dingdang Health Buys Back 0.51 Million Shares, Expands Treasury Stock to 14.82 Million

Bulletin Express10-22 19:02

Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 513,500 ordinary shares on 22 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 0.855 to HKD 0.885, translating to a volume-weighted average of HKD 0.8651 per share and an aggregate consideration of HKD 0.44 million.

Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell by 0.04 % to 1.23 billion, while treasury shares rose to 14.82 million. The company’s total issued share capital remains unchanged at 1.24 billion shares, as the repurchased stock is being held in treasury and not yet cancelled.

The buyback formed part of the repurchase mandate approved on 23 June 2026, under which the company may repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 17.68 million shares, equivalent to 1.42 % of the issued share base on the mandate date. In line with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share disposals until 21 November 2026.

Company Secretary Lam Yiu Por confirmed that the transactions were executed in full compliance with the Hong Kong Stock Exchange’s Main Board Rules and all relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184716068?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-22 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184716068","market":"hk","top_or_hot":-1,"title":"Dingdang Health Buys Back 0.51 Million Shares, Expands Treasury Stock to 14.82 Million","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 513,500 ordinary shares on 22 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 0.855 to HKD 0.885, translating to a volume-weighted average of HKD 0.8651 per share and an aggregate consideration of HKD 0.44 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell by 0.04 % to 1.23 billion, while treasury shares rose to 14.82 million. The company’s total issued share capital remains unchanged at 1.24 billion shares, as the repurchased stock is being held in treasury and not yet cancelled.</p>\n<p>The buyback formed part of the repurchase mandate approved on 23 June 2026, under which the company may repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 17.68 million shares, equivalent to 1.42 % of the issued share base on the mandate date. In line with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share disposals until 21 November 2026.</p>\n<p>Company Secretary Lam Yiu Por confirmed that the transactions were executed in full compliance with the Hong Kong Stock Exchange’s Main Board Rules and all relevant legal requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Buys Back 0.51 Million Shares, Expands Treasury Stock to 14.82 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Buys Back 0.51 Million Shares, Expands Treasury Stock to 14.82 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-22 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 513,500 ordinary shares on 22 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 0.855 to HKD 0.885, translating to a volume-weighted average of HKD 0.8651 per share and an aggregate consideration of HKD 0.44 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell by 0.04 % to 1.23 billion, while treasury shares rose to 14.82 million. The company’s total issued share capital remains unchanged at 1.24 billion shares, as the repurchased stock is being held in treasury and not yet cancelled.</p>\n<p>The buyback formed part of the repurchase mandate approved on 23 June 2026, under which the company may repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 17.68 million shares, equivalent to 1.42 % of the issued share base on the mandate date. In line with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share disposals until 21 November 2026.</p>\n<p>Company Secretary Lam Yiu Por confirmed that the transactions were executed in full compliance with the Hong Kong Stock Exchange’s Main Board Rules and all relevant legal requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1184716068","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184716068","pubTimestamp":1792666974,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 513,500 ordinary shares on 22 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康回购51万股，库存股增至1482万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 513,500 ordinary shares on 22 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 0.855 to HKD 0.885, translating to a volume-weighted average of HKD 0.8651 per share and an aggregate consideration of HKD 0.44 million.\nFollowing the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell by 0.04 % to 1.23 billion, while treasury shares rose to 14.82 million. The company’s total issued share capital remains unchanged at 1.24 billion shares, as the repurchased stock is being held in treasury and not yet cancelled.\nThe buyback formed part of the repurchase mandate approved on 23 June 2026, under which the company may repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 17.68 million shares, equivalent to 1.42 % of the issued share base on the mandate date. In line with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share disposals until 21 November 2026.\nCompany Secretary Lam Yiu Por confirmed that the transactions were executed in full compliance with the Hong Kong Stock Exchange’s Main Board Rules and all relevant legal requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184716068","isCrawlerRequest":true}